Clinical Trial Update: Camrelizumab in Combination With Apatinib in Advanced ICC: A Single-arm Phase II Study [Phase 2]

View source ↗

Summary

Phase II single-arm trial evaluating camrelizumab with apatinib for advanced intrahepatic cholangiocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• Apatinib (apatinib)
• Camrelizumab (camrelizumab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Intrahepatic Cholangiocarcinoma | Phase 2 | Status: UNKNOWN